SCNI
Price
$2.24
Change
+$0.09 (+4.19%)
Updated
Jul 8 closing price
Capitalization
2.24M
VANI
Price
$1.27
Change
-$0.00 (-0.00%)
Updated
Jul 8 closing price
Capitalization
75.24M
41 days until earnings call
Interact to see
Advertisement

SCNI vs VANI

Header iconSCNI vs VANI Comparison
Open Charts SCNI vs VANIBanner chart's image
Scinai Immunotherapeutics
Price$2.24
Change+$0.09 (+4.19%)
Volume$45.44K
Capitalization2.24M
Vivani Medical
Price$1.27
Change-$0.00 (-0.00%)
Volume$69.77K
Capitalization75.24M
SCNI vs VANI Comparison Chart in %
Loading...
SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SCNI vs. VANI commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCNI is a Hold and VANI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (SCNI: $2.24 vs. VANI: $1.27)
Brand notoriety: SCNI and VANI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SCNI: 7% vs. VANI: 66%
Market capitalization -- SCNI: $2.24M vs. VANI: $75.24M
SCNI [@Biotechnology] is valued at $2.24M. VANI’s [@Biotechnology] market capitalization is $75.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.49B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SCNI’s FA Score shows that 2 FA rating(s) are green whileVANI’s FA Score has 0 green FA rating(s).

  • SCNI’s FA Score: 2 green, 3 red.
  • VANI’s FA Score: 0 green, 5 red.
According to our system of comparison, SCNI is a better buy in the long-term than VANI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SCNI’s TA Score shows that 3 TA indicator(s) are bullish while VANI’s TA Score has 3 bullish TA indicator(s).

  • SCNI’s TA Score: 3 bullish, 6 bearish.
  • VANI’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, VANI is a better buy in the short-term than SCNI.

Price Growth

SCNI (@Biotechnology) experienced а -10.04% price change this week, while VANI (@Biotechnology) price change was +0.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.39%. For the same industry, the average monthly price growth was +14.41%, and the average quarterly price growth was +12.94%.

Reported Earning Dates

SCNI is expected to report earnings on May 07, 2025.

VANI is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+9.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VANI($75.2M) has a higher market cap than SCNI($2.24M). VANI YTD gains are higher at: 9.483 vs. SCNI (-33.034). SCNI has higher annual earnings (EBITDA): 7.8M vs. VANI (-24.6M). VANI has more cash in the bank: 13M vs. SCNI (1.03M). SCNI has less debt than VANI: SCNI (1.23M) vs VANI (18.9M). SCNI has higher revenues than VANI: SCNI (452K) vs VANI (0).
SCNIVANISCNI / VANI
Capitalization2.24M75.2M3%
EBITDA7.8M-24.6M-32%
Gain YTD-33.0349.483-348%
P/E Ratio1.19N/A-
Revenue452K0-
Total Cash1.03M13M8%
Total Debt1.23M18.9M6%
FUNDAMENTALS RATINGS
SCNI vs VANI: Fundamental Ratings
SCNI
VANI
OUTLOOK RATING
1..100
9226
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8100
PRICE GROWTH RATING
1..100
8747
P/E GROWTH RATING
1..100
76100
SEASONALITY SCORE
1..100
5029

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SCNI's Valuation (18) in the Pharmaceuticals Major industry is somewhat better than the same rating for VANI (54) in the null industry. This means that SCNI’s stock grew somewhat faster than VANI’s over the last 12 months.

SCNI's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as VANI (100) in the null industry. This means that SCNI’s stock grew similarly to VANI’s over the last 12 months.

SCNI's SMR Rating (8) in the Pharmaceuticals Major industry is significantly better than the same rating for VANI (100) in the null industry. This means that SCNI’s stock grew significantly faster than VANI’s over the last 12 months.

VANI's Price Growth Rating (47) in the null industry is somewhat better than the same rating for SCNI (87) in the Pharmaceuticals Major industry. This means that VANI’s stock grew somewhat faster than SCNI’s over the last 12 months.

SCNI's P/E Growth Rating (76) in the Pharmaceuticals Major industry is in the same range as VANI (100) in the null industry. This means that SCNI’s stock grew similarly to VANI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SCNIVANI
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 14 days ago
79%
Bullish Trend 12 days ago
80%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
SCNI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VANI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SCL59.191.62
+2.81%
Stepan Co
VTSI6.590.07
+1.07%
VirTra
NFBK11.99-0.01
-0.08%
Northfield Bancorp
FN286.36-0.30
-0.10%
Fabrinet
IMG0.23-0.03
-9.95%
CIMG Inc

SCNI and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCNI has been closely correlated with TAOX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if SCNI jumps, then TAOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCNI
1D Price
Change %
SCNI100%
+4.19%
TAOX - SCNI
73%
Closely correlated
+7.47%
SYRE - SCNI
43%
Loosely correlated
+2.03%
MBIO - SCNI
37%
Loosely correlated
-20.36%
BIVI - SCNI
34%
Loosely correlated
+4.57%
VANI - SCNI
32%
Poorly correlated
N/A
More

VANI and

Correlation & Price change

A.I.dvisor indicates that over the last year, VANI has been loosely correlated with VTVT. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if VANI jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VANI
1D Price
Change %
VANI100%
N/A
VTVT - VANI
60%
Loosely correlated
+7.45%
ADIL - VANI
37%
Loosely correlated
-2.33%
AXSM - VANI
36%
Loosely correlated
+0.85%
GLSI - VANI
35%
Loosely correlated
+0.20%
SCNI - VANI
34%
Loosely correlated
+4.19%
More